Liver disease-related methods and systems

Details Liver disease-related methods and systems Liver disease-related methods and systems

2004-06-15

2010-02-23

Zeman, Mary K (Department: 1631)

Data processing: measuring, calibrating, or testing

Measurement system in a specific environment

Biological or biochemical

C702S020000, C707S793000, C703S011000, C435S007100

Reexamination Certificate

active

07668661

ABSTRACT:
The invention provides diagnostic methods, kits, and systems, and related computer-readable media, which use multiple blood marker values, including serum and plasma marker values, to aid in the diagnosis of the status or progress of a liver disease in a patient.The invention also provides methods and systems, and related computer-readable media, that use blood marker values, including serum and plasma marker values: (1) to screen for active ingredients useful in the treatment of a liver disease; (2) to aid in the selection of treatment regimens for patients that are predisposed to, or suffer from, liver disease; and (3) to aid in the design of clinical programs useful in monitoring the status or progress of liver disease in one or more patients.

REFERENCES:
patent: 5019498 (1991-05-01), Chichibu
patent: 5316914 (1994-05-01), Oshima et al.
patent: 6000828 (1999-12-01), Leet
patent: 7225080 (2007-05-01), Poynard
patent: 2004/0053242 (2004-03-01), Volker et al.
patent: 1150123 (2006-12-01), None
patent: 1283989 (2007-07-01), None
patent: WO 01/86304 (2001-11-01), None
patent: WO0186304 (2001-11-01), None
Pilette et al. Histopathological evaluation of Liver Fibrosis: quantitive image analysis vs simi-quantitative scores 1998. vol. 28, pp. 439-446.
International Search Report PCT/US05/21002-Filed: Jun. 15, 2005.
Alexandrakis et al., “Use of a Variety of Biological Parameters in Distinguishing Cirrhotic From Malignant Ascites,” Int. J. Biol. Markers, 16:45-49, 2001.
H. Franklin Bunn & Wendell Rosse, “Hemolytic Anemias and Acute Blood Loss,” inHarrison's Principles of Internal Medicine, 681, 681 (Eugene Braunwald, Stephen L. Hauser, Anthony S. Fauchi, Dan L. Longo, Dennis L. Kasper & J. Larry Jameson eds., McGraw-Hill 15thed. 2001.
Daniluk et al., “Serum Cytokine Levels in Alcohol-Related Liver Cirrhosis,” Alcohol, 23:29-34, 2001.
Henry N. Ginsberg & Ira J. Goldberg,Disorders of Lipoprotein Metabolism, in Harrison's Principles of Internal Medicine, 2245, 2246-2247 (Eugene Braunwald, Stephen L. Hauser, Anthony S. Fauchi, Dan L. Longo, Dennis L. Kasper & J. Larry Jameson eds., McGraw-Hill 15thed 2001.
Jensen et al., “Collagen: Scaffold for Repair or Execution,” Cardiovasc. Res. 33:535-539, 1997.
Kerrigan et al., “Matrix Turnover,” J. Orthod., 27:227-233, 2000.
Daniel S. Pratt & Marshall M. Kaplan,Evaluation of Liver Function, in Harrison's Principles of Internal Medicine, 1714, 1711-1714 (Eugene Braunwald, Stephen L. Hauser, Anthony S. Fauchi, Dan L. Longo, Dennis L. Kasper & J. Larry Jameson eds., McGraw-Hill 15thed. 2001).
Peter J. Quesenberry & Gerald A Colvin,Hematopoiesis, in Harrison's Principles of Internal Medicine, 653, 655-657 (Eugene Braunwald, Stephen L. Hauser, Anthony S. Fauchi, Dan L. Longo, Dennis L. Kasper & J. Larry Jameson eds., McGraw-Hill 15thed 2001.
S. Ramakrishnan et al.,Textbook of Medical Biochemistry, 155-158 (Orient BlackSwan 3rded. 2004).
Rochling, “Evaluation of Abnormal Liver Tests,” Clin. Cornerstone, 3(6):1-12, 2001.
Shah et al., “Apolipoprotein Deficiency and Chronic Liver Disease,” J. Assoc. Physicians India, 49:274-278, 2001.
Poon T C-W et al: “Application of Classification Tree and Neural Network Algorithms to the Identification of Serological Liver Marker Profiles for the Diagnosis of Hepatocellular Carcinoma” Oncology, S. Karger, Basel, CH, vol. 61, No. 4, 1 Nov. 001, pp. 275- 283, XP009044316 ISSN: 0030-2414 2001.
Fortunato G et al: “Multivariate Discriminant Function Based on Six Biochemical Markers in Blood Can Predict the Cirrhotic Evolution of Chronic Hepatitis” Clinical Chemistry, American Association for Clinical Chemistry, Washington, DC, vol. 47, No. 9, 1. Sep. 2001, pp. 1696- 1700, XP002996105 ISSN: 0009-9147 “abstract” 2001.
Duda R et al: “Pattern Classification - Chapter 1” 2001, John Wiley & Sons, New York, US, XP002536377, pp. 14-17 2001.
Sylvie Naveau et al: “Alpha -2- Macroglobulin and Hepatic Fibrosis - Diagnostic Interest”, Digestive Diseases and Sciences, vol. 39, No. 11, Nov. 1994.
Giuseppe Castaldo: “Differential diagnosis between heptocellular carcinoma and cirrhosis through a discriminant function based on results for serum analytes”, Clinical Chemistry, vol. 42, No. 8, 1996.
D. Schuppan et al: “Serummarker der Leberfibrose”, Deutsche medizinische Wochenzeitschrift, Nr. 124, 1999.
Ji Xuhuai et al: “Clinical significance of serum 7S collagen and type VI collagen levels for the diagnosis of hepatic fibrosis”, Chinese Medical Journal 1997, 110(3), 1997.
J P Teare et al: “Comparison of serum procollagen III peptide concentrations and PGA index for assessment of hepatic fibrosis”, The Lancet, vol. 342, 1993.
J. Guechot et al: “Diagnostic accuracy of hyaluronan and type III procollagen amino- terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis”, Clinical Chemistry, vol. 42, No. 4, 1996.
Enrico Rossi et al: “Validation of the Fibro TEst Biochemical Markers Score in Assessing Liver Fibrosis in Hepatitis C Patients” Clinical Chemistry vol. 49, No. 3, 2003.
Christophe Pilette et al: “Histopathological evaluation of liver fibrosis: quantitative image analysis vs smiquantitative scores - Comparison with serum markers”, Journal of Hepatology, 1998, vol. 28.

Affiliated with

Also associated with

Rating

Liver disease-related methods and systems does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Liver disease-related methods and systems, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Liver disease-related methods and systems will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4225890